Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638007 · ClinicalTrials.gov registry record
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
A clinical trial, sponsored by University of Rochester NCORP Research Base.
- Recruiting
- Registry status
- 400
- Enrollment target
NCT07638007 is a clinical trial that is actively recruiting participants, run by University of Rochester NCORP Research Base. The registered enrollment target is 400 participants.
The verdict
NCT07638007 is actively recruiting participants, sponsored by University of Rochester NCORP Research Base.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2029-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07638007
The ClinicalTrials.gov registry entry for NCT07638007 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester NCORP Research Base, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07638007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07638007 about?
NCT07638007 is a clinical study titled "Impact of Targeted Therapy on Cancer-Related Cognitive Impairment". This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
What is the current status of trial NCT07638007?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-11-21. Estimated completion is 2029-02-28.
Who is sponsoring clinical trial NCT07638007?
This trial is sponsored by University of Rochester NCORP Research Base, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.